Stocks
Intellia Therapeutics (NTLA) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -106.4 | -136.6 | -267.9 | -458.2 | -515.3 | -537.7 | |||
| Changes by years, y/y, % | +17% | +28% | +96% | +71% | +12% | +41.5% | |||
Intellia Therapeutics. Operating Income, bln rub
Intellia Therapeutics. Operating Income, changes, %
Intellia Therapeutics. Operating Income, sum by quarters, bln rub
Intellia Therapeutics (NTLA) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | -131.1 | -139.9 | -114.0 | -139.0 | -144.8 | -537.7 | ||
| Changes by years, y/y, % | +24% | +27% | +2% | +5% | +10% | |||
| Changes by quarters, q/q, % | -1% | +7% | -19% | +22% | +4% | |||
